Eris Lifesciences Ltd reports consolidated net profit of Rs. 101.85 crores in Q3 FY2023

Eris Lifesciences Limited has reported Consolidated financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 425.495 crores during the period ended December 31, 2022 as compared to Rs. 465.684 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 101.859 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 120.304 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 7.49 for the period ended December 31, 2022 as compared to Rs. 8.84 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹425.495 crs	₹465.684 crs	-8.63%
Net Profit	₹101.859 crs	₹120.304 crs	-15.33%
EPS	₹7.49	₹8.84	-15.27%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.425.495 crores during the period ended December 31, 2022 as compared to Rs.337.335 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.101.859 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.100.765 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.7.49 for the period ended December 31, 2022 as compared to Rs.7.41 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹425.495 crs	₹337.335 crs	26.13%
Net Profit	₹101.859 crs	₹100.765 crs	1.09%
EPS	₹7.49	₹7.41	1.08%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.1292.50 crores during the 9 Months period ended December 31, 2022 as compared to Rs.1059.127 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.316.740 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.325.817 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.23.28 for the 9 Months period ended December 31, 2022 as compared to Rs.23.97 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹1292.50 crs	₹1059.127 crs	22.03%
Net Profit	₹316.740 crs	₹325.817 crs	-2.79%
EPS	₹23.28	₹23.97	-2.88%

Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 651.80 as compared to the previous close of Rs. 648.70. The total number of shares traded during the day was 15798 in over 2939 trades.

The stock hit an intraday high of Rs. 653.95 and intraday low of 645.80. The net turnover during the day was Rs. 10270385.00.

Source : Equity Bulls

Keywords

ErisLifesciences Q3FY23 9MFY23 ResultUpdate